BMJ2d
Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures
Objectives Systemic sclerosis (SSc) is a heterogeneous disease, complicating its management. Its complexity and the ...
BMJ6d
Single-cell transcriptomics reveal potent extrafollicular B cell response linked with granzyme K + CD8 T cell activation in lupus kidney
2 Key Laboratory of Immune Response and Immunotherapy, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China 3 University of Chinese Academy of Sciences, Beijing, ...
BMJ1d
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis
15 Department of Radiology. Leiden University Medical Centre, Leiden, The Netherlands 16 Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands ...
BMJ2d
Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging
Background: Magnetic resonance imaging (MRI) is increasingly used to detect inflammation in the spine of patients with ankylosing spondylitis (AS). Objectives: To detect differentially the presence ...
BMJ3d
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Objective To assess the efficacy/safety of tofacitinib in adult patients with active ankylosing spondylitis (AS). Methods This phase III, randomised, double-blind, placebo-controlled study enrolled ...
BMJ3d
Stress fracture of the sacrum in a child
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ3d
The history of osteoarthritis-osteoarthrosis
ProfessorDr J Dequeker, Department of Rheumatology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium; jan.dequeker{at}med.kuleuven.be The history of osteoarthritis-osteoarthrosis ...
BMJ6d
Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system
Eamonn S Molloy, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA; molloye{at}ccf.org Objective ...
BMJ1d
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
Background The European Scleroderma Trials and Research Group (EUSTAR) recently developed a preliminarily revised activity index (AI) that performed better than the European Scleroderma Study Group ...
BMJ4d
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
2 Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Austria Background and objectives Instruments for measuring disease activity in psoriatic arthritis (PsA) are not ...
BMJ1d
FRI0362 Mineralized, Pegylated Hyaluronic Acid Nanoparticles for Ph-Responsive Delivery of Methotrexate in Inflammatory Arthritis
Background Targeted delivery to inflamed joint and site specific drug release are the key factors for effective therapy against inflammatory arthritis. The critical dose-limiting factor for ...
BMJ6d
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study
Correspondence to Dr Lindi Jiang, Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China; zsh-rheum{at}hotmail.com Antineutrophil cytoplasm antibody-associated ...